{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:33:37Z","timestamp":1764786817658,"version":"3.46.0"},"reference-count":14,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","award":["2211-05603"],"award-info":[{"award-number":["2211-05603"]}],"id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI171110"],"award-info":[{"award-number":["U19AI171110"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Inflammatory bowel disease (IBD) treatments and pregnancy can independently modulate immune responses, but the combined impacts on SARS-CoV-2 vaccine-induced immunity are poorly understood. This study explores the efficacy of SARS-CoV-2 vaccination and placental antibody transfer among pregnant women with IBD on biologic therapies. This observational study included pregnant women with and without IBD from the PIANO and PREVENT-COVID studies and their neonates. We assessed anti-SARS-CoV-2 neutralizing antibody titers (NT50) in maternal and cord blood post-vaccination using a pseudotype neutralization assay and calculated placental transfer ratios. A total of 32 pregnant women participated, and 27 were exposed to a biologic medication during pregnancy. Neutralizing antibody titers were similar between biologic-treated and non-treated groups, and biologic-exposed women demonstrated robust placental transfer of neutralizing antibodies. Corticosteroid use during pregnancy was significantly associated with reduced placental transfer efficiency, although this effect was not significant in a sensitivity analysis excluding patients treated with immunomodulators. Vaccination timing and SARS-CoV-2 infection impacted maternal and cord antibody levels, with higher titers observed in those vaccinated before pregnancy or infected during pregnancy. Overall, our findings suggest that upon vaccination, pregnant women with IBD on biologic therapies mount effective SARS-CoV-2 neutralizing antibody responses similar to their non-biologic-exposed counterparts, with efficient placental transfer. These findings support the efficacy of SARS-CoV-2 vaccination in this population, though further research with larger cohorts is needed for validation and to explore the long-term protective effects of transferred antibodies in neonates. Furthermore, corticosteroid use, immunomodulator use, and vaccination timing may influence antibody dynamics, underscoring the need for tailored clinical management in this vulnerable population.<\/jats:p>","DOI":"10.1371\/journal.pone.0321242","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:29:05Z","timestamp":1764786545000},"page":"e0321242","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-vaccination SARS-CoV-2 neutralizing antibodies in pregnant women receiving biologics for inflammatory bowel disease"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4494-1705","authenticated-orcid":true,"given":"Donna E.","family":"Leet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles S.","family":"Craik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Kattah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Millie D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"7","key":"pone.0321242.ref001","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/ibd\/izab337","article-title":"Outcomes of COVID-19 infections in vaccinated patients with inflammatory bowel disease: data from an international registry","volume":"28","author":"E Spiera","year":"2022","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"pone.0321242.ref002","first-page":"303","article-title":"Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study","volume":"225","author":"KJ Gray","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"pone.0321242.ref003","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S2468-1253(22)00005-X","article-title":"COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study","volume":"7","author":"JL Alexander","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"pone.0321242.ref004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S2468-1253(22)00389-2","article-title":"Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4\/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study","volume":"8","author":"Z Liu","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"pone.0321242.ref005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamapediatrics.2021.5683","article-title":"Maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at delivery after receipt of the BNT162b2 messenger RNA COVID-19 vaccine during the second trimester of pregnancy","volume":"176","author":"N Kugelman","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"2","key":"pone.0321242.ref006","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajog.2021.03.035","article-title":"Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy","volume":"225","author":"LB Mithal","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"pone.0321242.ref007","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"DS Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"1","key":"pone.0321242.ref008","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1038\/s41467-020-18468-8","article-title":"SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood","volume":"11","author":"DL Ng","year":"2020","journal-title":"Nat Commun"},{"issue":"11","key":"pone.0321242.ref009","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3390\/vaccines10111833","article-title":"SARS-CoV-2 IgG antibody levels in women with IBD vaccinated during pregnancy","volume":"10","author":"BI Biron","year":"2022","journal-title":"Vaccines"},{"issue":"1","key":"pone.0321242.ref010","doi-asserted-by":"crossref","first-page":"100492","DOI":"10.1016\/j.ajogmf.2021.100492","article-title":"Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy","volume":"4","author":"O Nir","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"1","key":"pone.0321242.ref011","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1038\/s41467-022-31169-8","article-title":"Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms","volume":"13","author":"CG Atyeo","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"pone.0321242.ref012","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1038\/s41467-022-32188-1","article-title":"Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy","volume":"13","author":"M Prahl","year":"2022","journal-title":"Nat Commun"},{"key":"pone.0321242.ref013","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3389\/fimmu.2017.01294","article-title":"Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy","volume":"8","author":"CR Wilcox","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"pone.0321242.ref014","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-002985","article-title":"Maternal and neonatal antibody levels on pertussis vaccination in pregnant women on immune-modulating therapy for rheumatic disease","volume":"9","author":"N Ghalandari","year":"2023","journal-title":"RMD Open"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:29:09Z","timestamp":1764786549000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321242"}},"subtitle":[],"editor":[{"given":"Yury E","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":14,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0321242","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}